DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Atenolol


Collection D4 : CTD
Chemical Name Atenolol ( From PubChem : ATENOLOL )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
266.336 g/mol 3 5 1.5433 True
Structure
InChI InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)/t12-/m1/s1
InChIKey METKIMKYRPQLGS-GFCCVEGCSA-N
Links

Gene (43 / 120)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(reaction)ABCB11
D001262
CTDincreases(transport)ABCB11
D001262
CTDdecreases(activity)ABCB11
D001262
CTDaffects(response to substance)ADRA2A
D001262
CTDaffects(response to substance)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDdecreases(activity)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDdecreases(activity)ADRB1
D001262
CTDdecreases(reaction)ADRB1
D001262
CTDincreases(expression)ADRB1
D001262
CTDincreases(phosphorylation)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDdecreases(abundance)ADRB1
D001262
CTDdecreases(activity)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDdecreases(activity)ADRB1
D001262
CTDdecreases(response to substance)ADRB1
D001262
CTDaffects(cotreatment)ADRB1
D001262
CTDincreases(abundance)ADRB1
D001262
CTDaffects(binding)ADRB1
D001262
CTDdecreases(reaction)ADRB1
D001262
CTDincreases(abundance)ADRB1
D001262
CTDdecreases(reaction)ADRB1
D001262
CTDincreases(activity)ADRB1
D001262
CTDdecreases(reaction)ADRB1
D001262
CTDdecreases(activity)ADRB1
D001262
CTDaffects(binding)ADRB2
D001262
CTDincreases(abundance)ADRB2
D001262
CTDincreases(phosphorylation)ADRB2
D001262
CTDaffects(binding)ADRB2
D001262
CTDdecreases(activity)ADRB2
D001262
CTDdecreases(abundance)ADRB2
D001262
CTDaffects(binding)ADRB2
D001262
CTDdecreases(reaction)ADRB2
D001262
CTDincreases(activity)ADRB2
D001262
CTDincreases(abundance)ADRB2
D001262
CTDdecreases(reaction)ADRB2
D001262
CTDincreases(expression)ADRB2
D001262
CTDaffects(binding)ADRB3
D001262
CTDdecreases(reaction)ADRB3
D001262
CTDaffects(response to substance)AGT
D001262
CTDdecreases(expression)AGT
D001262
CTDdecreases(expression)APOA1
D001262
CTDdecreases(expression)APOA2
D001262
CTDincreases(expression)APOB
D001262
CTDincreases(expression)APOB
D001262
CTDdecreases(reaction)ATF1
D001262
CTDincreases(phosphorylation)ATF1
D001262
CTDdecreases(expression)B2M
D001262
CTDaffects(response to substance)BDKRB2
D001262
CTDincreases(response to substance)CACNA1C
D001262
CTDdecreases(reaction)CASP3
D001262
CTDincreases(activity)CASP3
D001262
CTDincreases(expression)CLEC2B
D001262
CTDdecreases(reaction)CREB1
D001262
CTDincreases(phosphorylation)CREB1
D001262
CTDaffects(response to substance)EDN1
D001262
CTDdecreases(reaction)EGFR
D001262
CTDincreases(phosphorylation)EGFR
D001262
CTDdecreases(reaction)FAS
D001262
CTDincreases(expression)FAS
D001262
CTDdecreases(reaction)FASLG
D001262
CTDincreases(expression)FASLG
D001262
CTDaffects(binding)FKBP1B
D001262
CTDincreases(reaction)FKBP1B
D001262
CTDdecreases(expression)FKBP5
D001262
CTDdecreases(reaction)INS
D001262
CTDincreases(expression)INS
D001262
CTDaffects(response to substance)KCNJ2
D001262
CTDaffects(response to substance)KCNQ1
D001262
CTDaffects(metabolic processing)LIPC
D001262
CTDaffects(response to substance)LIPC
D001262
CTDaffects(binding)MAPK1
D001262
CTDincreases(phosphorylation)MAPK1
D001262
CTDaffects(binding)MAPK1
D001262
CTDdecreases(activity)MAPK1
D001262
CTDdecreases(reaction)MAPK1
D001262
CTDincreases(phosphorylation)MAPK1
D001262
CTDdecreases(reaction)MAPK1
D001262
CTDincreases(phosphorylation)MAPK1
D001262
CTDaffects(binding)MAPK3
D001262
CTDincreases(phosphorylation)MAPK3
D001262
CTDaffects(binding)MAPK3
D001262
CTDdecreases(activity)MAPK3
D001262
CTDdecreases(reaction)MAPK3
D001262
CTDincreases(phosphorylation)MAPK3
D001262
CTDdecreases(reaction)MAPK3
D001262
CTDincreases(phosphorylation)MAPK3
D001262
CTDdecreases(expression)NPPA
D001262
CTDincreases(expression)NPPB
D001262
CTDaffects(metabolic processing)PLA2G4C
D001262
CTDaffects(response to substance)PLA2G4C
D001262
CTDaffects(binding)PTGS2
D001262
CTDdecreases(activity)PTGS2
D001262
CTDdecreases(reaction)PTGS2
D001262
CTDincreases(expression)PTGS2
D001262
CTDaffects(cotreatment)REN
D001262
CTDdecreases(activity)REN
D001262
CTDdecreases(activity)REN
D001262
CTDdecreases(expression)REN
D001262
CTDaffects(cotreatment)REN
D001262
CTDincreases(secretion)REN
D001262
CTDaffects(binding)RYR2
D001262
CTDincreases(reaction)RYR2
D001262
CTDincreases(activity)RYR2
D001262
CTDdecreases(expression)SLC19A1
D001262
CTDdecreases(reaction)SLC22A1
D001262
CTDincreases(uptake)SLC22A1
D001262
CTDdecreases(expression)SLC6A8
D001262
CTDincreases(expression)SLCO4C1
D001262
CTDincreases(expression)SNORA49
D001262
CTDincreases(expression)SNRPN
D001262
CTDdecreases(reaction)SOD1
D001262
CTDincreases(activity)SOD1
D001262
CTDdecreases(reaction)SOD2
D001262
CTDincreases(activity)SOD2
D001262
CTDincreases(expression)TXN
D001262
ChEMBLSelectivity-ADRB1
-Target : CHEMBL213
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).